British Journal of Urology · 2003 · 15 citations · 20 references
These results suggest that Ad5CMV-p21 may be a new therapeutic agent for human prostate cancer gene therapy.
20
WAF1, a potential mediator of p53 tumor suppression
Wafik S. El‐Deiry, Takashi Tokino, Victor E. Velculescu et al. · Cell · 1993 · 8.4K citations
Robert T. Greenlee, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 2000 · 3.9K citations · Full text
American Cancer Society, Cancer Statistics, Cancer Epidemiology +14
p21 is a universal inhibitor of cyclin kinases
Yue Xiong, Gregory J. Hannon, Hui Zhang et al. · Nature · 1993 · 3.4K citations
Receptor Tyrosine Kinase, Cyclin Kinases, Anti-cancer Agent +4